Copy and paste this code to insert a reference to this article in your
blog or online community profile:
First-Line Maintenance with Olaparib and Bevacizumab for Ovarian Cancer
Current Trends Gynecol Oncol, 7: 113. 7:2, (2022)
https://doi.org/10.4172/ctgo.1000113
Highlight
Will Display Like this:
First-Line Maintenance with Olaparib and Bevacizumab for Ovarian Cancer
Current Trends Gynecol Oncol, 7: 113. 7:2, (2022)
https://doi.org/10.4172/ctgo.1000113
Powered by
OMICS International